This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The two interventions were admission to a telemetry setting versus admission to an unmonitored setting.
Location/setting
USA/emergency department.
Methods

Analytical approach:
The analysis was based on a decision-tree model, for a hypothetical, 55-year-old patient with low-risk chest pain, but otherwise healthy. A lifetime horizon was considered. The authors stated that the analysis was carried out from a societal perspective.
Effectiveness data:
The clinical data appear to have been from a selection of relevant sources. Most of the studies were conducted in the USA and a number of simplifying assumptions were made. The prevalence of acute coronary syndrome was a key input for the model.
Monetary benefit and utility valuations:
The utility values were derived from a published review of various health states and quality of life.
Measure of benefit:
Quality-adjusted life-years (QALYs) were the summary benefit measure and were discounted at an annual rate of 3%.
Cost data:
The economic analysis included the costs of telemetry, delayed telemetry hospital admission, hospitalisation for chest pain or dysrhythmia, and cardiac arrest from myocardial infarction (until discharge or death), and the annual costs of disability and coma. The costs and resource quantities were from Medicare reimbursement rates, National Physician Fee Schedules, and published studies. The cost of telemetry was from the authors' institution. All costs were in US dollars ($) and the price year was 2009. The long-term costs were discounted at an annual rate of 3%.
